US Bancorp
IMVT icon

US Bancorp’s Immunovant IMVT Stock Holding History

US Bancorp’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Buy
443
+87
+24% +$2.65K ﹤0.01% 3272
2026
Q1 		$8.84K Buy
356
+56
+19% +$1.45K ﹤0.01% 3396
2025
Q4 		$7.63K Sell
300
-146
-33% -$3.26K ﹤0.01% 3416
2025
Q3 		$7.19K Buy
446
+10
+2% +$162 ﹤0.01% 3421
2025
Q2 		$6.98K Sell
436
-1,184
-73% -$17.9K ﹤0.01% 3536
2025
Q1 		$27.7K Sell
1,620
-137
-8% -$2.87K ﹤0.01% 3029
2024
Q4 		$43.5K Buy
1,757
+58
+3% +$1.65K ﹤0.01% 2803
2024
Q3 		$48.4K Sell
1,699
-596
-26% -$17.6K ﹤0.01% 2756
2024
Q2 		$60.6K Sell
2,295
-241
-10% -$6.86K ﹤0.01% 2572
2024
Q1 		$81.9K Sell
2,536
-531
-17% -$19.4K ﹤0.01% 2459
2023
Q4 		$129K Buy
3,067
+77
+3% +$2.83K ﹤0.01% 2227
2023
Q3 		$115K Buy
2,990
+31
+1% +$701 ﹤0.01% 2083
2023
Q2 		$56.1K Sell
2,959
-43
-1% -$802 ﹤0.01% 2451
2023
Q1 		$46.6K Buy
3,002
+43
+1% +$746 ﹤0.01% 2559
2022
Q4 		$52.5K Buy
2,959
+1,582
+115% +$19.9K ﹤0.01% 2501
2022
Q3 		$8K Buy
1,377
+731
+113% +$3.57K ﹤0.01% 3448
2022
Q2 		$3K Buy
646
+11
+2% +$48 ﹤0.01% 3734
2022
Q1 		$3K Sell
635
-302
-32% -$1.88K ﹤0.01% 3747
2021
Q4 		$8K Sell
937
-115
-11% -$949 ﹤0.01% 3504
2021
Q3 		$9K Buy
+1,052
New +$9.49K ﹤0.01% 3481

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

US Bancorp's IMVT Position: Q2 2026 in Review

US Bancorp increased its Immunovant (IMVT) stake by 24% in Q2 2026, buying an estimated $2.65K and bringing the position to 443 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3272.

US Bancorp first reported a position in IMVT in Q3 2021 and has held it in 20 quarters since. The position peaked at $129K in Q4 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • US Bancorp held 443 shares of Immunovant worth $17.1K as of Q2 2026.
  • US Bancorp bought 87 Immunovant shares in Q2 2026, an estimated $2.65K.
  • Immunovant made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3272 holding.
  • US Bancorp first reported a position in Immunovant in Q3 2021 and has held it in 20 quarters since.
  • US Bancorp's Immunovant position peaked at $129K in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.